Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Foote

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Cancer Immunology Research|May 10, 2017
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized MiceJeremy B Foote, Marleen Kok, James M Leatherman, et al.
JCI Insight|May 11, 2026
Antibody subclass deficiency accelerates tumorigenesis in genetically engineered mouse models of pancreatic cancerJeremy B Foote, Sujith Sarvesh, Sameer Al Diffalha, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 2, 2021
Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 MiceHuixian Hong, Fatima Alduraibi, David Ponder, et al.
Annals of Surgical Oncology|November 28, 2024
Predictors of Recurrence in Nonmetastatic Appendiceal Epithelial Cancers: An Updated Single-Center Experience Over 25 YearsNicole Aguirre, Sebastian K Chung, Michael B Foote, et al.
Annals of Surgical Oncology|November 22, 2024
ASO Visual Abstract: Predictors of Recurrence in Non-metastatic Appendiceal Epithelial Cancers-An Updated Single Center Experience over 25 YearsNicole Aguirre, Sebastian K Chung, Michael B Foote, et al.
Carcinogenesis|August 4, 2025
Constitutive Epidermal Expression of Osteopontin in Osteopontin-Null Mice Restores Ultraviolet B-Induced Cutaneous Squamous Cell Carcinomas to Wild-Type LevelsChu-Fang Chou, Yun Huang, Jeremy B Foote, et al.
Xenotransplantation|October 23, 2023
In vitro and in vivo immune assessments of genetically-engineered pig skin grafts in New World (squirrel) monkeysHidetaka Hara, Jeremy B Foote, Christophe Hansen-Estruch, et al.
NPJ Precision Oncology|June 8, 2026
Variable efficacy of the non-covalent KRAS<sup>G12D</sup> inhibitor (MRTX-1133) with obesity in murine pancreatic cancerSujith Sarvesh, Holly Stephens, Pia Muri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid TumorsPaul Johannet, Somer Abdelfattah, Callahan Wilde, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
IFNγ-induced IRF1 synergizes with TLR7 signals to tune the IRF4-IRF8 axis and drive pathogenic effector B cell fateEddie-Williams Owiredu, Ashley J Denslow, Suki Chen, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Cancer Immunology Research|May 10, 2017
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized MiceJeremy B Foote, Marleen Kok, James M Leatherman, et al.
JCI Insight|May 11, 2026
Antibody subclass deficiency accelerates tumorigenesis in genetically engineered mouse models of pancreatic cancerJeremy B Foote, Sujith Sarvesh, Sameer Al Diffalha, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 2, 2021
Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 MiceHuixian Hong, Fatima Alduraibi, David Ponder, et al.
Annals of Surgical Oncology|November 28, 2024
Predictors of Recurrence in Nonmetastatic Appendiceal Epithelial Cancers: An Updated Single-Center Experience Over 25 YearsNicole Aguirre, Sebastian K Chung, Michael B Foote, et al.
Annals of Surgical Oncology|November 22, 2024
ASO Visual Abstract: Predictors of Recurrence in Non-metastatic Appendiceal Epithelial Cancers-An Updated Single Center Experience over 25 YearsNicole Aguirre, Sebastian K Chung, Michael B Foote, et al.
Carcinogenesis|August 4, 2025
Constitutive Epidermal Expression of Osteopontin in Osteopontin-Null Mice Restores Ultraviolet B-Induced Cutaneous Squamous Cell Carcinomas to Wild-Type LevelsChu-Fang Chou, Yun Huang, Jeremy B Foote, et al.
Xenotransplantation|October 23, 2023
In vitro and in vivo immune assessments of genetically-engineered pig skin grafts in New World (squirrel) monkeysHidetaka Hara, Jeremy B Foote, Christophe Hansen-Estruch, et al.
NPJ Precision Oncology|June 8, 2026
Variable efficacy of the non-covalent KRAS<sup>G12D</sup> inhibitor (MRTX-1133) with obesity in murine pancreatic cancerSujith Sarvesh, Holly Stephens, Pia Muri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid TumorsPaul Johannet, Somer Abdelfattah, Callahan Wilde, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
IFNγ-induced IRF1 synergizes with TLR7 signals to tune the IRF4-IRF8 axis and drive pathogenic effector B cell fateEddie-Williams Owiredu, Ashley J Denslow, Suki Chen, et al.
Pageof 17